FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management

Dockets Entered On June 8, 2007
Docket # Title
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
2003N-0573 Draft Animal Cloning Risk Assessment
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
2006P-0173 Request approval of any abbreviated new drug application relying on Zosyn (piperacillin and tazobactam for injection) as its reference product be contingent upon the proposed product
2006P-0394 Revise the labeling requirements for eggs sold in the United States
2007D-0117 Guidance for Industry on Orally Disintegrating Tablets
2007N-0121 Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
2007P-0224 ANDA Suitability Petition for NDA 21-774 Ambien CR (Zolpidem tartrate)
2007P-0226 to permit an ANDA suitability for Donepezil Hydrochloride Orally Dissolving Film Stripps, 5 mg and 10 mg
1997S-0162 30-Day Structure Function Claim Notification Letters Dietary
LET 19920 Enzyme Therapy, Inc. Vol #: 175
LET 19921 Enzyme Therapy, Inc. Vol #: 175
LET 19922 Enzymatic Therapy, Inc. Vol #: 175
LET 19923 Enzymatic Therapy, Inc. Vol #: 175
LET 19924 Enzymatic Therapy, Inc. Vol #: 175
LET 19925 Enzymatic Therapy, Inc. Vol #: 175
LET 19926 Alltech, Inc. Vol #: 175
LET 19927 Enzymatic Therapy, Inc. Vol #: 175
LET 19928 Enzymatic Therapy, Inc. Vol #: 175
LET 19929 Enzymatic Therapy, Inc. Vol #: 175
LET 19930 Enzymatic Therapy, Inc. Vol #: 175
LET 19931 Enzymatic Therapy, Inc. Vol #: 175
LET 19932 Enzymatic Therapy, Inc. Vol #: 175
LET 19933 Enzymatic Therapy, Inc. Vol #: 175
LET 19934 Enzymatic Therapy, Inc. Vol #: 175
LET 19935 Enzymatic Therapy, Inc. Vol #: 175
LET 19936 NBTY Inc. Vol #: 175
LET 19937 NBTY Inc. Vol #: 175
LET 19938 NBTY Inc. Vol #: 175
LET 19939 NBTY Inc. Vol #: 175
LET 19940 NBTY Inc. Vol #: 175
LET 19941 NBTY Inc. Vol #: 175
LET 19942 NBTY Inc. Vol #: 175
LET 19943 NBTY Inc. Vol #: 175
LET 19944 HERB PHARM Vol #: 175
LET 19945 Eu Yan Sang (Hong Kong) Limited Vol #: 175
LET 19946 Univera LifeSciences, Inc. Vol #: 175
LET 19947 Source Naturals Vol #: 175
LET 19948 Source Naturals Vol #: 175
LET 19949 Enzymatic Therapy, Inc. Vol #: 175
LET 19950 Enzymatic Therapy, Inc. Vol #: 175
LET 19951 Enzymatic Therapy, Inc. Vol #: 175
LET 19952 Enzymatic Therapy, Inc. Vol #: 175
LET 19953 Phytosolution Nutraceutical Systems llc Vol #: 175
LET 19954 Phytosolution Nutraceutical Systems llc Vol #: 175
LET 19955 Phytosolution Nutraceutical Systems llc Vol #: 175
LET 19956 Phytosolution Nutraceutical Systems llc Vol #: 175
LET 19957 Phytosolution Nutraceutical Systems llc Vol #: 175
LET 19958 Taisho Pharmaceutical CA, Inc. Vol #: 175
LET 19959 Eu Yan Sang (Hong Kong) Limited Vol #: 175
LET 19960 HERB PHARM Vol #: 175
LET 19961 HERB PHARM Vol #: 175
LET 19962 HERB PHARM Vol #: 175
LET 19963 HERB PHARM Vol #: 175
LET 19964 HERB PHARM Vol #: 175
LET 19965 HERB PHARM Vol #: 175
LET 19966 HERB PHARM Vol #: 175
LET 19967 AdvoCare Vol #: 175
LET 19968 Sante' Active, Inc. Vol #: 175
LET 19969 EQUAVIE Vol #: 175
LET 19970 EQUAVIE Vol #: 175
LET 19971 EQUAVIE Vol #: 175
LET 19972 EQUAVIE Vol #: 175
LET 19973 EQUAVIE Vol #: 175
LET 19974 EQUAVIE Vol #: 175
LET 19975 Chenko Inc. Vol #: 175
LET 19976 NBTY Vol #: 175
LET 19977 NBTY Vol #: 175
LET 19978 Pure Encapsulations Vol #: 175
LET 19979 Source Naturals Vol #: 175
LET 19980 Taisho Pharmaceutical CA, Inc. Vol #: 175
LET 19981 Orenda Internatyional, LLC Vol #: 175
LET 19982 CardioTabs, Inc. Vol #: 175
LET 19983 Orenda International, LLC Vol #: 175
LET 19984 ChildLife Vol #: 175
LET 19985 Pfantastic Medical Research Institute, LLC Vol #: 175
LET 19986 Boots Retail USA Inc. Vol #: 175
LET 19987 Boots Retail USA Inc. Vol #: 175
LET 19988 Boots Retail USA Inc. Vol #: 175
LET 19989 Boots Retail USA Inc. Vol #: 175
LET 19990 Boots Retail USA Inc. Vol #: 175
LET 19991 Boots Retail USA Inc. Vol #: 175
LET 19992 Boots Retail USA Inc. Vol #: 175
LET 19993 Enzymatic Therapy Inc. Vol #: 175
2003N-0573 Draft Animal Cloning Risk Assessment
C 1334 J. Ungar Vol #: 68
C 1335 P. Crane Vol #: 68
C 1336 N. Gordon Vol #: 68
C 1337 R. Garcia Vol #: 68
C 1338 L. Graham Vol #: 68
C 1339 B. Wardle Vol #: 68
C 1340 T. Christon Vol #: 68
C 1341 C. Camp Vol #: 68
C 1342 S. Mehrotra Vol #: 68
C 1343 M. Wade Vol #: 68
C 1344 P. Stone Vol #: 68
C 1345 M. Guenther Vol #: 68
C 1346 M. Lovato Vol #: 68
C 1347 J. Julien Vol #: 68
C 1348 J. Halloran Vol #: 68
C 1349 J. Tessmer Vol #: 68
C 1350 L. Wikstrom Vol #: 68
C 1351 E. Smith Vol #: 68
C 1352 T. Peralta Vol #: 68
C 1353 S. McDonald Vol #: 68
C 1354 M. Converse Vol #: 68
C 1355 M. Ventrella Vol #: 68
C 1356 K. Grag Vol #: 68
C 1357 M. Steele Vol #: 68
C 1358 J. Otto Vol #: 68
C 1359 M. Shanahan Vol #: 68
C 1360 N. Polsue Vol #: 68
C 1361 M. Genoa Vol #: 68
C 1362 S. Camp Vol #: 68
C 1363 K. Oda Vol #: 68
C 1364 L. Pucci Vol #: 68
C 1365 C. Thiel Vol #: 68
C 1366 V. Fong Vol #: 68
C 1367 S. McNamara Vol #: 68
C 1368 M. Bronsnan Vol #: 68
C 1369 T. Barney Vol #: 68
C 1370 T. Schuster Vol #: 68
C 1371 S. Bolar Vol #: 68
C 1372 T. Cafferty Vol #: 68
C 1373 R. Steinfurth Vol #: 68
C 1374 L. Vavrick Vol #: 68
C 1375 V. Sawyer Vol #: 68
C 1376 S. Guerrero Vol #: 68
C 1377 E. Boyd Vol #: 68
C 1378 R. Schroeter Vol #: 68
C 1379 A. Klein Vol #: 68
C 1380 O. Bielawski Vol #: 68
C 1381 L. Deets Vol #: 68
C 1382 L. Deets Vol #: 68
C 1383 R. Anderlik Vol #: 68
C 1384 M. Gordon Vol #: 68
C 1385 J. Turner Vol #: 68
C 1386 N. Andresen Vol #: 68
C 1387 J. Filip Vol #: 68
C 1388 C. Wolfe Vol #: 68
C 1389 M. Mangiarelli Vol #: 68
C 1390 C. Johnson Vol #: 68
C 1391 D. Silverman Vol #: 68
C 1392 L. Doleshal Vol #: 68
C 1393 J. Shore Vol #: 68
C 1394 J. Lester Vol #: 68
C 1395 D. Iregui Vol #: 68
C 1396 D. Jankowski Vol #: 68
C 1397 M. Argo Vol #: 68
C 1398 Y. Silva Vol #: 68
C 1399 M. Gilbert Vol #: 68
C 1400 L. Franks Vol #: 68
C 1401 N. Procopio Vol #: 68
C 1402 S. Johnson Vol #: 68
C 1403 C. Huleva Vol #: 68
C 1404 A. Dellago Vol #: 68
C 1405 K. Marin Vol #: 68
C 1406 M. McDonald Vol #: 68
C 1407 C. Madden Vol #: 68
C 1408 T. Hicks Vol #: 68
C 1409 G. Haley Vol #: 68
C 1410 L. Hamblin Vol #: 68
C 1411 K. Genetive Vol #: 68
C 1412 M. Neilsen Vol #: 68
C 1413 P. Gerresheim Vol #: 68
C 1414 A. Cabada Vol #: 68
C 1415 M. Lasater Vol #: 68
C 1416 M. Aitken Vol #: 68
C 1417 L. Wells Vol #: 68
C 1418 J. Martin Vol #: 68
C 1419 T. Newman Vol #: 68
C 1420 A. Drechaler Vol #: 68
C 1421 S. Greenlee Vol #: 68
C 1422 K. Goetze Vol #: 68
C 1423 V. Barro Vol #: 68
C 1424 K. Wyatt Vol #: 68
C 1425 A. Alessandra Vol #: 68
C 1426 B. Towles Vol #: 68
C 1427 C. Graney Vol #: 68
C 1428 C. Haia Vol #: 68
C 1429 J. Brown Vol #: 68
C 1430 J. Slominski Vol #: 68
C 1431 P. Newman Vol #: 68
C 1432 M. McCormick Vol #: 68
C 1433 M. Robichaud Vol #: 68
C 1434 C. Mozuch Vol #: 68
C 1435 R. Simmons Vol #: 68
C 1436 K. Barowitz Vol #: 68
C 1437 D. Rasnake Vol #: 68
C 1438 P. Patterson Vol #: 68
C 1439 B. Luther Vol #: 68
C 1440 N. Lubin Vol #: 68
C 1441 J. Bruning Vol #: 68
C 1442 SD Coggin Vol #: 68
C 1443 C. Zimmerman Vol #: 68
C 1444 A. White Vol #: 68
C 1445 D. Adney Vol #: 207
C 1446 L. Eagle Vol #: 207
C 1447 H. Walker Vol #: 207
C 1448 L. Kroll Vol #: 207
C 1449 C. Airing Vol #: 207
C 1450 P. Moss Vol #: 207
C 1451 D. Gagliarducci Vol #: 207
C 1452 S. Campbell Vol #: 207
C 1453 M. Valli Vol #: 207
C 1454 W. Herbert Vol #: 207
C 1455 K. Piazza Vol #: 207
2005P-0411 Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
C 18315 L. Calmes Vol #: 198
2006P-0173 Request approval of any abbreviated new drug application relying on Zosyn (piperacillin and tazobactam for injection) as its reference product be contingent upon the proposed product
SUP 4 Wyeth Laboratories Vol #: 1
2006P-0394 Revise the labeling requirements for eggs sold in the United States
C 99 C. Maszk, T. Green & J. Green Vol #: 7
2007D-0117 Guidance for Industry on Orally Disintegrating Tablets
C 3 Schering-Plough Vol #: 1
C 4 Bristol-Myers Squibb Company Vol #: 1
C 5 Sanofi Aventis Vol #: 1
C 6 Novartis Pharmaceuticals Corp. Vol #: 1
EC 6 sanofi-aventis Vol #: 1
EC 7 Perrigo Company Vol #: 1
2007N-0121 Use of Medication Guides to Distribute Drug Risk Information to Patients; Public Hearing
EAPE 266 Melfi, Catherine Vol #: 7
EAPE 267 Mehta, Rikin Vol #: 7
EAPE 268 Vincent, Andrea Vol #: 7
EAPE 269 De Santis, Marta Vol #: 7
EAPE 270 Robbins, Gabriel Vol #: 7
2007P-0224 ANDA Suitability Petition for NDA 21-774 Ambien CR (Zolpidem tartrate)
ACK 1 FDA/DDM to Sanofi Aventis U.S. Inc. Vol #: 1
CP 1 Sanofi Aventis U.S. Inc. Vol #: 1
2007P-0226 to permit an ANDA suitability for Donepezil Hydrochloride Orally Dissolving Film Stripps, 5 mg and 10 mg
ACK 1 FDA / DDM to Lachman Consultant Services, Inc. Vol #: 1
CP 1 Lachman Consultant Services, Inc. Vol #: 1

Page created on June 8, 2007 ue

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management